Global Report on Active Pharmaceutical Ingredients Market Size Will Reach to USD 258.3 Billion by 2026: Facts & Factors

Facts & Factors
·8 min read

[225+ Pages Research Report] According to the recent research report; the global Active Pharmaceutical Ingredient Market in 2019 was approximately USD 177.6 Billion. The market is expected to surge at a CAGR of 5.5% and is anticipated to surpass USD 258.3 Billion by 2026. Top market players in the market are Abbvie Inc., Dr. Reddy’s Laboratories Ltd, Eli Lilly and Company, Cipla, Bristol Myers Squibb, Boehringer Ingelheim GmbH and others.

New York, NY, April 12, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled “Active Pharmaceutical Ingredient Market By Type (Innovative APIs, and Generic APIS), By Manufacturer (Captive Manufacturers, and Merchant Manufacturers), By Type of Synthesis (Synthetic, and Biotech), By Drug Type (Prescription Drugs, and Over-the-counter Drugs), and By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026”.

“According to the research report, the global Active Pharmaceutical Ingredient Market was estimated at USD 177.6 Billion in 2019 and is expected to reach USD 258.3 Billion by 2026. The global Active Pharmaceutical Ingredient Market is expected to grow at a compound annual growth rate (CAGR) of 5.5% from 2019 to 2026”.

Active Pharmaceutical Ingredient Market: Overview and Definition

APIs are synthetic and organically dynamic components of drugs that have a direct effect on disease cure, moderation, care, and counteraction. Because of the increased use of medications and biologics in the treatment of diseases, the global API market has grown dramatically in recent decades. The growing use of value models in API manufacturing, such as Good Manufacturing Practices (GMP) and current GMP (cGMP), as well as the global acceptance of International Conference on Harmonization (ICH) laws, has strengthened security guidelines. On the other hand, the API industry is facing challenges such as reducing development time, lowering development costs, improving process structure, and meeting quality requirements without sacrificing profit.

Request to Download Your Free Sample Report of Active Pharmaceutical Ingredient Market @ https://www.fnfresearch.com/sample/active-pharmaceutical-ingredient-market

(The free sample of this report is readily available on request).

Our Free Sample Report Includes:

  • 2020 Updated Report Introduction, Overview, and In-depth industry analysis

  • COVID-19 Pandemic Outbreak Impact Analysis Included

  • 190+ Pages Research Report (Inclusion of Updated Research)

  • Provide Chapter-wise guidance on Request

  • 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends

  • Includes Updated List of table & figures

  • Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis

  • Facts and Factors research methodology

(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)

Key Questions Answered in this Report

1) What were the pre and post-business impacts of COVID-19 on the Active Pharmaceutical Ingredient Market?

2) What is the market size, share of the Active Pharmaceutical Ingredient Market?

3) Who are the top market players in Active Pharmaceutical Ingredient Market?

4) What will be the future market of the Active Pharmaceutical Ingredient Market?

Key Offerings:

  • Market Size & Forecast by Revenue | 2020−2026

  • Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities

  • Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography

  • Competitive Landscape – Top key vendors and other prominent vendors

Inquire more about this report before purchase @ https://www.fnfresearch.com/inquiry/active-pharmaceutical-ingredient-market

(You may enquire a report quote OR available discount offers to our sales team before purchase.)

Active Pharmaceutical Ingredient Market: Industry Major Market Players

  • Cipla

  • Bristol Myers Squibb

  • Boehringer Ingelheim GmbH

  • BASF SE

  • Aurobindo Pharma

  • Albemarle Corporation

  • Abbvie Inc.

  • Dr. Reddy’s Laboratories Ltd

  • Eli Lilly and Company

  • Viatris Inc

  • Teva Pharmaceutical Industries Ltd

  • Sun Pharmaceutical Industries Ltd

  • Sanofi

  • Pfizer Inc.

  • Novartis AG

  • Mylan NV

  • Merck & Co.

  • Lupin Ltd

To know an additional revised 2020 list of market players, request a sample report: https://www.fnfresearch.com/sample/active-pharmaceutical-ingredient-market

Active Pharmaceutical Ingredient Market: Market Dynamics

Advances in active pharmaceutical ingredient (API) manufacturing, as well as the increasing prevalence of chronic diseases like cardiovascular disease and cancer, are both contributing to the rise. Government policies that encourage API demand, as well as shifts in geopolitical circumstances, are propelling the market forward. The API market is experiencing significant changes as a result of COVID-19's supply chain disruption. Due to geopolitical circumstances and a desire to minimize reliance on China for API goods, countries such as India are being favored over China for API export. Furthermore, several governments have devised policies and provided incentives to encourage the development of goods.

Increased R&D programs for novel drug production, as well as favorable government legislation, are credited with the growth of the innovative APIs market. Many products are now in the pipeline as a result of extensive research in this area and are expected to be launched during the forecast era. The competition is expected to be driven by new entrants.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/active-pharmaceutical-ingredient-market

In 2020, the synthetic API segment had the highest revenue share of 69.97 % this is due to the increased availability of raw materials and the ease with which these molecules can be synthesized. Many synthetic molecules are also expected to become off-patent in the coming years, boosting development.

Over the forecast era, the biotech segment is projected to develop at the fastest CAGR of 7.2%. Factors such as rising demand for biopharmaceuticals and higher molecule efficiency are propelling this segment forward. Furthermore, high investments in the biotechnology and biopharmaceutical sectors can be attributed to the biotech segment's growth. This opens the door to the development of new molecules that help in the treatment of diseases like cancer. Biotech-related API's high revenue makes the industry highly lucrative, attracting major players. For example, Clinigen, Inc.'s Proleukin (aldesleukin) is a biologic therapy for metastatic renal cell carcinoma.

Global Active Pharmaceutical Ingredient Market: Growth Factor

The growing activity for research and development on drug production increased popularity of generic products, and the use of biopharmaceuticals, are the key factors driving the growth of the global active pharmaceutical industry. The unfavorable policies of price regulation for drugs in different countries and high production costs are, however, likely to hamper demand growth.

The growing prevalence of chronic diseases would raise the demand for medicines, which is projected to accelerate the market growth of active pharmaceutical ingredients in the immediate future. The world's leading cause of death was cardiovascular diseases, estimating about 17.9 million lives a year, according to the WHO.

Around 5.8 million people in the U.S. were reported to suffer from Alzheimer's in 2018 by the Alzheimer's Association. The illness is the sixth most common cause of death for people over 65 years of age in the United States. The population of baby booms is estimated to reach 14 million and to intensify in the projected timeframe, approaching the age of about 65. By 2050, every 33 seconds a new case of this disease could arise.

Request Customized Copy of Report @ https://www.fnfresearch.com/customization/active-pharmaceutical-ingredient-market

(We customize your report according to your research need. Ask our sales team for report customization.)

North America is projected to Dominate Global Active Pharmaceutical Ingredients Market Growth

North America had the highest market share of 41.5 percent in 2019 and is projected to hold that position during the forecast period. This can be due to the increasing epidemiology of cancer and other lifestyle-related diseases, which encourages R&D and thus boosts business growth.

During the forecast era, Asia Pacific is expected to have the highest CAGR of 7.4%. The presence of economies like China and India, which the world relies on for low-cost API production, is a benefit for the region. The market is expected to rise due to rising healthcare expenditure in the region.

Browse the full “Active Pharmaceutical Ingredient Market By Type (Innovative APIs, and Generic APIS), By Manufacturer (Captive Manufacturers, and Merchant Manufacturers), By Type of Synthesis (Synthetic, and Biotech), By Drug Type (Prescription Drugs, and Over-the-counter Drugs), and By Therapeutic Application (Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026” report at https://www.fnfresearch.com/active-pharmaceutical-ingredient-market

The global active pharmaceutical ingredients market is segmented as follows:

By Type:

  • Innovative APIs

  • Generic APIs

By Manufacturer:

  • Captive Manufacturers

  • Merchant Manufacturers

By Type of Synthesis:

  • Synthetic

  • Biotech

By Drug Type:

  • Prescription Drugs

  • Over-the-counter Drugs

By Therapeutic Application:

  • Communicable Diseases

  • Oncology, Diabetes

  • Cardiovascular Disease

  • Pain management

  • Respiratory Diseases

  • Others

For media/report purchase inquiry, email us at sales@fnfresearch.com

Related Reports:

Pyridine Market: https://www.fnfresearch.com/pyridine-market-by-product-type-pyridine-n-oxide-1234

Erectile Dysfunction Drugs Market: https://www.fnfresearch.com/erectile-dysfunction-drugs-market

Antimalarial Drugs Market: https://www.fnfresearch.com/antimalarial-drugs-market-by-drug-class-quinine-chloroquine-1128

Diarrhea Drug Market: https://www.fnfresearch.com/diarrhea-drug-market-product-type-adult-diarrhea-drug-857

Pharmacokinetics Services Market: https://www.fnfresearch.com/pharmacokinetics-services-market-by-drug-type-large-molecules-979

About Facts & Factors (FnF Research):

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us Twitter: https://twitter.com/fnfresearch

Contact Us:

Facts & Factors

USA: +1-347-989-3985

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com